Skip Nav Destination
An endothelial metronome breast cancer?
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia
Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993
Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2)
Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction
An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens
Rituximab for steroid-refractory chronic graft-versus-host disease
Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency
Issue Archive
July 15 2006
In this Issue
Table of Contents
INSIDE BLOOD
CLINICAL TRIALS AND OBSERVATIONS
An endothelial metronome breast cancer?
Clinical Trials & Observations
PERSPECTIVES
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia
Clinical Trials & Observations
Bruce D. Cheson,Peter L. Greenberg,John M. Bennett,Bob Lowenberg,Pierre W. Wijermans,Stephen D. Nimer,Antonio Pinto,Miloslav Beran,Theo M. de Witte,Richard M. Stone,Moshe Mittelman,Guillermo F. Sanz,Steven D. Gore,Charles A. Schiffer,Hagop Kantarjian
REVIEW ARTICLES
CHEMOKINES, CYTOKINES, AND INTERLEUKINS
CLINICAL TRIALS AND OBSERVATIONS
Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group
Clinical Trials & Observations
Joanne M. Hilden,Patricia A. Dinndorf,Sharon O. Meerbaum,Harland Sather,Doojduen Villaluna,Nyla A. Heerema,Ron McGlennen,Franklin O. Smith,William G. Woods,Wanda L. Salzer,Helen S. Johnstone,Zoann Dreyer,Gregory H. Reaman
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy
Clinical Trials & Observations
Patrizia Mancuso,Marco Colleoni,Angelica Calleri,Laura Orlando,Patrick Maisonneuve,Giancarlo Pruneri,Alice Agliano,Aron Goldhirsch,Yuval Shaked,Robert S. Kerbel,Francesco Bertolini
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993
Clinical Trials & Observations
Hillard M. Lazarus,Susan M. Richards,Raj Chopra,Mark R. Litzow,Alan K. Burnett,Peter H. Wiernik,Ian M. Franklin,Martin S. Tallman,Lucy Cook,Georgina Buck,I. Jill Durrant,Jacob M. Rowe,Anthony H. Goldstone,for the Medical Research Council (MRC)/National Cancer Research Institute (NCRI) Adult Leukaemia Working Party of the United Kingdom and the Eastern Cooperative Oncology Group
Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2)
Clinical Trials & Observations
Tadeusz Robak,Jerzy Z. Blonski,Joanna Gora-Tybor,Krzysztof Jamroziak,Jadwiga Dwilewicz-Trojaczek,Agnieszka Tomaszewska,Lech Konopka,Bernadetta Ceglarek,Anna Dmoszynska,Malgorzata Kowal,Janusz Kloczko,Beata Stella-Holowiecka,Kazimierz Sulek,Malgorzata Calbecka,Krystyna Zawilska,Kazimierz Kuliczkowski,Aleksander B. Skotnicki,Krzysztof Warzocha,Marek Kasznicki,the Polish Leukemia Group (PALG CLL2)
GENE THERAPY
HEMATOPOIESIS
Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response
Inga Köllner,Beate Sodeik,Sabine Schreek,Holger Heyn,Nils von Neuhoff,Manuela Germeshausen,Cornelia Zeidler,Martin Krüger,Brigitte Schlegelberger,Karl Welte,Carmela Beger
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
ICSBP/IRF-8 differentially regulates antigen uptake during dendritic-cell development and affects antigen presentation to CD4+ T cells
Fabrizio Mattei,Giovanna Schiavoni,Paola Borghi,Massimo Venditti,Irene Canini,Paola Sestili,Immacolata Pietraforte,Herbert C. Morse, III,Carlo Ramoni,Filippo Belardelli,Lucia Gabriele
NEOPLASIA
Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl–expressing human leukemia cells
Warren Fiskus,Michael Pranpat,Purva Bali,Maria Balasis,Sandhya Kumaraswamy,Sandhya Boyapalle,Kathy Rocha,Jie Wu,Francis Giles,Paul W. Manley,Peter Atadja,Kapil Bhalla
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma
Abel Sánchez-Aguilera,Carlos Montalbán,Paloma de la Cueva,Lydia Sánchez-Verde,Manuel M. Morente,Mónica García-Cosío,José García-Laraña,Carmen Bellas,Mariano Provencio,Vicens Romagosa,Alberto Fernández de Sevilla,Javier Menárguez,Pilar Sabín,María J. Mestre,Miguel Méndez,Manuel F. Fresno,Concepción Nicolás,Miguel A. Piris,Juan F. García,for the Spanish Hodgkin Lymphoma Study Group
Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction
Clinical Trials & Observations
Carla S. Wilson,George S. Davidson,Shawn B. Martin,Erik Andries,Jeffrey Potter,Richard Harvey,Kerem Ar,Yuexian Xu,Kenneth J. Kopecky,Donna P. Ankerst,Holly Gundacker,Marilyn L. Slovak,Monica Mosquera-Caro,I-Ming Chen,Derek L. Stirewalt,Maurice Murphy,Frederick A. Schultz,Huining Kang,Xuefei Wang,Jerald P. Radich,Frederick R. Appelbaum,Susan R. Atlas,John Godwin,Cheryl L. Willman
OCT-1–mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib
Deborah L. White,Verity A. Saunders,Phuong Dang,Jane Engler,Andrew C. W. Zannettino,Antony C. Cambareri,Steven R. Quinn,Paul W. Manley,Timothy P. Hughes
Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors
Meili Zhang,Zhengsheng Yao,Zhuo Zhang,Kayhan Garmestani,Carolyn K. Goldman,Jeffrey V. Ravetch,John Janik,Martin W. Brechbiel,Thomas A. Waldmann
Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study
Deepa Bhojwani,Huining Kang,Naomi P. Moskowitz,Dong-Joon Min,Hokyung Lee,Jeffrey W. Potter,George Davidson,Cheryl L. Willman,Michael J. Borowitz,Ilana Belitskaya-Levy,Stephen P. Hunger,Elizabeth A. Raetz,William L. Carroll
PHAGOCYTES
FcγR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways
Latha P. Ganesan,Trupti Joshi,Huiqing Fang,Vijay Kumar Kutala,Julie Roda,Rossana Trotta,Amy Lehman,Periannan Kuppusamy,John C. Byrd,William E. Carson,Michael A. Caligiuri,Susheela Tridandapani
RED CELLS
STEM CELLS IN HEMATOLOGY
TRANSFUSION MEDICINE
TRANSPLANTATION
An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens
Clinical Trials & Observations
Wendy M. Leisenring,Paul J. Martin,Effie W. Petersdorf,Anne E. Regan,Nada Aboulhosn,Jean M. Stern,Saundra N. Aker,Raymond C. Salazar,George B. McDonald
Rituximab for steroid-refractory chronic graft-versus-host disease
Clinical Trials & Observations
Corey Cutler,David Miklos,Haesook T. Kim,Nathaniel Treister,Sook-Bin Woo,Don Bienfang,Lloyd B. Klickstein,Jesse Levin,Katherine Miller,Carol Reynolds,Rebecca Macdonell,Mildred Pasek,Stephanie J. Lee,Vincent Ho,Robert Soiffer,Joseph H. Antin,Jerome Ritz,Edwin Alyea
Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency
Clinical Trials & Observations
José A. Borghans,Robbert G. Bredius,Mette D. Hazenberg,Helene Roelofs,Els C. Jol-van der Zijde,Jeroen Heidt,Sigrid A. Otto,Taco W. Kuijpers,Willem E. Fibbe,Jaak M. Vossen,Frank Miedema,Maarten J. van Tol
CORRESPONDENCE
-
Cover Image
Cover Image
![issue cover]()
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement
Email alerts
Advertisement
